APA (7th ed.) Citation

IJ, O., K, C., GO, O., ES, O., K, M., AE, B., . . . MC, O. (2025). Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 32(1), 33. https://doi.org/10.1007/s40292-024-00682-w

Chicago Style (17th ed.) Citation

IJ, Ogieuhi, et al. "Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials." High Blood Pressure & Cardiovascular Prevention : The Official Journal of the Italian Society of Hypertension 32, no. 1 (2025): 33. https://doi.org/10.1007/s40292-024-00682-w.

MLA (9th ed.) Citation

IJ, Ogieuhi, et al. "Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials." High Blood Pressure & Cardiovascular Prevention : The Official Journal of the Italian Society of Hypertension, vol. 32, no. 1, 2025, p. 33, https://doi.org/10.1007/s40292-024-00682-w.